Unapproved Dose of Direct Oral Anticoagulants for Venous Thromboembolism ― Right or Wrong? ―
Author:
Affiliation:
1. Department of Cardiology, Nagoya University Hospital
2. Center for Advanced Medicine and Clinical Research, Department of Advanced Medicine, Nagoya University Hospital
Publisher
Japanese Circulation Society
Link
https://www.jstage.jst.go.jp/article/circj/88/3/88_CJ-24-0063/_pdf
Reference11 articles.
1. 1. Trujillo-Santos J, Di Micco P, Dentali F, Douketis J, Diaz-Peromingo JA, Nunez MJ, et al. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens. Thromb Haemost 2017; 117: 382–389.
2. 2. Angchaisuksiri P, Goto S, Farjat AE, Fryk H, Bang SM, Chiang CE, et al. Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. Thromb Res 2021; 201: 63–72.
3. 3. Nakamura M, Yamada N, Asamura T, Shiosakai K, Uchino K. Safety and effectiveness of edoxaban in Japanese venous thromboembolism patients: Final analysis of one-year follow-up data from a Japanese postmarketing observational study (ETNA-VTE-Japan). Circ Rep 2020; 2: 192–202.
4. 4. Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017; 376: 1211–1222.
5. 5. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013; 368: 699–708.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3